R. Greer
Vermögen: 1 Mio $ am 31.05.2026
Vermögen: 1 Mio $ am 31.05.2026
R.
Scott Greer was the founder of Abgenix, Inc., founded in 1996, where the title held was Chairman from 2002 to 2007.
Mr. Greer is the founder of Numenor Ventures LLC, founded in 2002, holding the title of Managing Director since 2002.
The current job is Independent Director at Nektar Therapeutics, starting in 2010.
Former jobs include Chairman at Ablexis LLC from 2010 to 2016; Chairman at Sirna Therapeutics, Inc. from 2005 to 2009; Chairman at Acologix, Inc.; Chairman at Calimmune, Inc. from 2015 to 2017; Independent Director at StemCells, Inc. from 2011 to 2016; Director at CV Therapeutics, Inc. from 2001 to 2004; Director at Illumina, Inc. from 2001 to 2005; Independent Director at Inogen, Inc. from 2015 to 2021; Director at BAROnova, Inc. from 2009 to 2013; Director at AnaptysBio, Inc. from 2007 to 2008; Director at Affymax, Inc. from 2000 to 2004; Independent Director at Project Sage Oldco, Inc. from 2014 to 2018; Director at Auspex Pharmaceuticals, Inc. from 2014 to 2015; Director at Versartis, Inc. from 2014 to 2018; Director at Auspex, Inc.; Director at Aravive, Inc. from 2014 to 2017; Senior Vice President-Corporate Development at Cell Genesys, Inc. in 1996; Senior Vice President-Corporate Development at Genetics Institute LLC from 1985 to 1991.
Education includes an undergraduate degree from Whitman College in 1981 and an MBAistration from Harvard Business School in 1985.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NEKTAR THERAPEUTICS 0,06 % | 06.04.2026 | 20 238 ( 0,06 % ) | 1 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NEKTAR THERAPEUTICS | Direktor/Vorstandsmitglied | 01.01.2010 |
Numenor Ventures LLC
Numenor Ventures LLC Investment ManagersFinance Numenor Ventures invests in both public and private companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Gründer | 01.01.2002 |
| Unternehmen | Position | Ende |
|---|---|---|
| INOGEN, INC. | Direktor/Vorstandsmitglied | 24.05.2021 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Direktor/Vorstandsmitglied | 12.10.2018 |
| PROJECT SAGE OLDCO, INC. | Direktor/Vorstandsmitglied | 01.07.2018 |
| ARAVIVE, INC. | Direktor/Vorstandsmitglied | 31.12.2017 |
Calimmune, Inc.
Calimmune, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Vorsitzender | 31.08.2017 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 23 |
|---|---|
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology Researches and develops stem cell therapeutics | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Nektar Therapeutics
Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides and develops pharmaceutical products | Commercial Services |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Health Technology |
Illumina, Inc.
Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Inogen, Inc.
Inogen, Inc. Medical SpecialtiesHealth Technology Operates as a medical technology company | Health Technology |
BAROnova, Inc.
BAROnova, Inc. Medical SpecialtiesHealth Technology Operates as a clinical-stage medical-device company | Health Technology |
AnaptysBio, Inc.
AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Acologix, Inc.
Acologix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines | Health Technology |
Affymax, Inc.
Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Whitman College
Whitman College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Project Sage Oldco, Inc.
Project Sage Oldco, Inc. Medical SpecialtiesHealth Technology Develops and sells medical aesthetics products | Health Technology |
Numenor Ventures LLC
Numenor Ventures LLC Investment ManagersFinance Numenor Ventures invests in both public and private companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Auspex Pharmaceuticals, Inc.
Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
Calimmune, Inc.
Calimmune, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Ablexis LLC
Ablexis LLC Packaged SoftwareTechnology Services Develops next-generation platform for antibody drug discovery | Technology Services |
Auspex, Inc. | |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aravive, Inc.
Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen